1 Market Overview 1.1 Human DNA Vaccines Product Introduction 1.2 Global Human DNA Vaccines Market Size Forecast 1.3 Human DNA Vaccines Market Trends & Drivers 1.3.1 Human DNA Vaccines Industry Trends 1.3.2 Human DNA Vaccines Market Drivers & Opportunity 1.3.3 Human DNA Vaccines Market Challenges 1.3.4 Human DNA Vaccines Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Human DNA Vaccines Players Revenue Ranking (2023) 2.2 Global Human DNA Vaccines Revenue by Company (2019-2024) 2.3 Key Companies Human DNA Vaccines Manufacturing Base Distribution and Headquarters 2.4 Key Companies Human DNA Vaccines Product Offered 2.5 Key Companies Time to Begin Mass Production of Human DNA Vaccines 2.6 Human DNA Vaccines Market Competitive Analysis 2.6.1 Human DNA Vaccines Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Human DNA Vaccines Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Recombinant Protein Vaccine 3.1.2 Gene-Based Vaccine 3.2 Global Human DNA Vaccines Sales Value by Type 3.2.1 Global Human DNA Vaccines Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Human DNA Vaccines Sales Value, by Type (2019-2030) 3.2.3 Global Human DNA Vaccines Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Influenza 4.1.2 Human Papillomavirus 4.1.3 HIV 4.2 Global Human DNA Vaccines Sales Value by Application 4.2.1 Global Human DNA Vaccines Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Human DNA Vaccines Sales Value, by Application (2019-2030) 4.2.3 Global Human DNA Vaccines Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Human DNA Vaccines Sales Value by Region 5.1.1 Global Human DNA Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Human DNA Vaccines Sales Value by Region (2019-2024) 5.1.3 Global Human DNA Vaccines Sales Value by Region (2025-2030) 5.1.4 Global Human DNA Vaccines Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Human DNA Vaccines Sales Value, 2019-2030 5.2.2 North America Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Human DNA Vaccines Sales Value, 2019-2030 5.3.2 Europe Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Human DNA Vaccines Sales Value, 2019-2030 5.4.2 Asia Pacific Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Human DNA Vaccines Sales Value, 2019-2030 5.5.2 South America Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Human DNA Vaccines Sales Value, 2019-2030 5.6.2 Middle East & Africa Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Human DNA Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Human DNA Vaccines Sales Value 6.3 United States 6.3.1 United States Human DNA Vaccines Sales Value, 2019-2030 6.3.2 United States Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Human DNA Vaccines Sales Value, 2019-2030 6.4.2 Europe Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Human DNA Vaccines Sales Value, 2019-2030 6.5.2 China Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.5.3 China Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Human DNA Vaccines Sales Value, 2019-2030 6.6.2 Japan Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Human DNA Vaccines Sales Value, 2019-2030 6.7.2 South Korea Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Human DNA Vaccines Sales Value, 2019-2030 6.8.2 Southeast Asia Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Human DNA Vaccines Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Human DNA Vaccines Sales Value, 2019-2030 6.9.2 India Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 6.9.3 India Human DNA Vaccines Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Merck 7.1.1 Merck Profile 7.1.2 Merck Main Business 7.1.3 Merck Human DNA Vaccines Products, Services and Solutions 7.1.4 Merck Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.1.5 Merck Recent Developments 7.2 GSK 7.2.1 GSK Profile 7.2.2 GSK Main Business 7.2.3 GSK Human DNA Vaccines Products, Services and Solutions 7.2.4 GSK Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.2.5 GSK Recent Developments 7.3 Sanofi 7.3.1 Sanofi Profile 7.3.2 Sanofi Main Business 7.3.3 Sanofi Human DNA Vaccines Products, Services and Solutions 7.3.4 Sanofi Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.3.5 Zoties Recent Developments 7.4 Zoties 7.4.1 Zoties Profile 7.4.2 Zoties Main Business 7.4.3 Zoties Human DNA Vaccines Products, Services and Solutions 7.4.4 Zoties Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.4.5 Zoties Recent Developments 7.5 Elanco 7.5.1 Elanco Profile 7.5.2 Elanco Main Business 7.5.3 Elanco Human DNA Vaccines Products, Services and Solutions 7.5.4 Elanco Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.5.5 Elanco Recent Developments 7.6 Boehringer-Ingelheim 7.6.1 Boehringer-Ingelheim Profile 7.6.2 Boehringer-Ingelheim Main Business 7.6.3 Boehringer-Ingelheim Human DNA Vaccines Products, Services and Solutions 7.6.4 Boehringer-Ingelheim Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.6.5 Boehringer-Ingelheim Recent Developments 7.7 Indian Immunologicals 7.7.1 Indian Immunologicals Profile 7.7.2 Indian Immunologicals Main Business 7.7.3 Indian Immunologicals Human DNA Vaccines Products, Services and Solutions 7.7.4 Indian Immunologicals Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.7.5 Indian Immunologicals Recent Developments 7.8 Plumbline Life Sciences 7.8.1 Plumbline Life Sciences Profile 7.8.2 Plumbline Life Sciences Main Business 7.8.3 Plumbline Life Sciences Human DNA Vaccines Products, Services and Solutions 7.8.4 Plumbline Life Sciences Human DNA Vaccines Revenue (US$ Million) & (2019-2024) 7.8.5 Plumbline Life Sciences Recent Developments 8 Industry Chain Analysis 8.1 Human DNA Vaccines Industrial Chain 8.2 Human DNA Vaccines Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Human DNA Vaccines Sales Model 8.5.2 Sales Channel 8.5.3 Human DNA Vaccines Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Human DNA Vaccines Market Trends Table 2. Human DNA Vaccines Market Drivers & Opportunity Table 3. Human DNA Vaccines Market Challenges Table 4. Human DNA Vaccines Market Restraints Table 5. Global Human DNA Vaccines Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Human DNA Vaccines Revenue Market Share by Company (2019-2024) Table 7. Key Companies Human DNA Vaccines Manufacturing Base Distribution and Headquarters Table 8. Key Companies Human DNA Vaccines Product Type Table 9. Key Companies Time to Begin Mass Production of Human DNA Vaccines Table 10. Global Human DNA Vaccines Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Human DNA Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Human DNA Vaccines Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Human DNA Vaccines Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Human DNA Vaccines Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Human DNA Vaccines Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Human DNA Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Human DNA Vaccines Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Human DNA Vaccines Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Human DNA Vaccines Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Human DNA Vaccines Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Human DNA Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Human DNA Vaccines Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Human DNA Vaccines Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Human DNA Vaccines Sales Value by Region (2019-2024) & (%) Table 27. Global Human DNA Vaccines Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Human DNA Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Human DNA Vaccines Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Human DNA Vaccines Sales Value, (2025-2030) & (US$ Million) Table 31. Merck Basic Information List Table 32. Merck Description and Business Overview Table 33. Merck Human DNA Vaccines Products, Services and Solutions Table 34. Revenue (US$ Million) in Human DNA Vaccines Business of Merck (2019-2024) Table 35. Merck Recent Developments Table 36. GSK Basic Information List Table 37. GSK Description and Business Overview Table 38. GSK Human DNA Vaccines Products, Services and Solutions Table 39. Revenue (US$ Million) in Human DNA Vaccines Business of GSK (2019-2024) Table 40. GSK Recent Developments Table 41. Sanofi Basic Information List Table 42. Sanofi Description and Business Overview Table 43. Sanofi Human DNA Vaccines Products, Services and Solutions Table 44. Revenue (US$ Million) in Human DNA Vaccines Business of Sanofi (2019-2024) Table 45. Sanofi Recent Developments Table 46. Zoties Basic Information List Table 47. Zoties Description and Business Overview Table 48. Zoties Human DNA Vaccines Products, Services and Solutions Table 49. Revenue (US$ Million) in Human DNA Vaccines Business of Zoties (2019-2024) Table 50. Zoties Recent Developments Table 51. Elanco Basic Information List Table 52. Elanco Description and Business Overview Table 53. Elanco Human DNA Vaccines Products, Services and Solutions Table 54. Revenue (US$ Million) in Human DNA Vaccines Business of Elanco (2019-2024) Table 55. Elanco Recent Developments Table 56. Boehringer-Ingelheim Basic Information List Table 57. Boehringer-Ingelheim Description and Business Overview Table 58. Boehringer-Ingelheim Human DNA Vaccines Products, Services and Solutions Table 59. Revenue (US$ Million) in Human DNA Vaccines Business of Boehringer-Ingelheim (2019-2024) Table 60. Boehringer-Ingelheim Recent Developments Table 61. Indian Immunologicals Basic Information List Table 62. Indian Immunologicals Description and Business Overview Table 63. Indian Immunologicals Human DNA Vaccines Products, Services and Solutions Table 64. Revenue (US$ Million) in Human DNA Vaccines Business of Indian Immunologicals (2019-2024) Table 65. Indian Immunologicals Recent Developments Table 66. Plumbline Life Sciences Basic Information List Table 67. Plumbline Life Sciences Description and Business Overview Table 68. Plumbline Life Sciences Human DNA Vaccines Products, Services and Solutions Table 69. Revenue (US$ Million) in Human DNA Vaccines Business of Plumbline Life Sciences (2019-2024) Table 70. Plumbline Life Sciences Recent Developments Table 71. Key Raw Materials Lists Table 72. Raw Materials Key Suppliers Lists Table 73. Human DNA Vaccines Downstream Customers Table 74. Human DNA Vaccines Distributors List Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources Table 78. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Human DNA Vaccines Product Picture Figure 2. Global Human DNA Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 4. Human DNA Vaccines Report Years Considered Figure 5. Global Human DNA Vaccines Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human DNA Vaccines Revenue in 2023 Figure 7. Human DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. Recombinant Protein Vaccine Picture Figure 9. Gene-Based Vaccine Picture Figure 10. Global Human DNA Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 11. Global Human DNA Vaccines Sales Value Market Share by Type, 2023 & 2030 Figure 12. Product Picture of Influenza Figure 13. Product Picture of Human Papillomavirus Figure 14. Product Picture of HIV Figure 15. Global Human DNA Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 16. Global Human DNA Vaccines Sales Value Market Share by Application, 2023 & 2030 Figure 17. North America Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 18. North America Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 Figure 19. Europe Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 20. Europe Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 Figure 21. Asia Pacific Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 22. Asia Pacific Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 Figure 23. South America Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 24. South America Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 Figure 25. Middle East & Africa Human DNA Vaccines Sales Value (2019-2030) & (US$ Million) Figure 26. Middle East & Africa Human DNA Vaccines Sales Value by Country (%), 2023 VS 2030 Figure 27. Key Countries/Regions Human DNA Vaccines Sales Value (%), (2019-2030) Figure 28. United States Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 29. United States Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 30. United States Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 31. Europe Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 32. Europe Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 33. Europe Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 34. China Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 35. China Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 36. China Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 37. Japan Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 38. Japan Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 39. Japan Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 40. South Korea Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 41. South Korea Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 42. South Korea Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 43. Southeast Asia Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 44. Southeast Asia Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 45. Southeast Asia Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 46. India Human DNA Vaccines Sales Value, (2019-2030) & (US$ Million) Figure 47. India Human DNA Vaccines Sales Value by Type (%), 2023 VS 2030 Figure 48. India Human DNA Vaccines Sales Value by Application (%), 2023 VS 2030 Figure 49. Human DNA Vaccines Industrial Chain Figure 50. Human DNA Vaccines Manufacturing Cost Structure Figure 51. Channels of Distribution (Direct Sales, and Distribution) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation